DeepMirror launches Early Access Programme for its intuitive molecular drug design software
DeepMirror, a University of Cambridge spin-out company developing intuitive design software for the discovery of novel therapeutic drugs, launched its Early Access Programme on 11 December 2023 after a successful closed beta programme during which chemists were invited to test the software over several months. The software allows users to tap into AI-driven insights to […]